首页> 外文学位 >Regulation of Syk activity in GPVI-mediated platelet activation.
【24h】

Regulation of Syk activity in GPVI-mediated platelet activation.

机译:在GPVI介导的血小板活化中Syk活性的调节。

获取原文
获取原文并翻译 | 示例

摘要

Activation of platelets is essential for hemostasis. Following damage to the vascular endothelium collagen is exposed, to which platelets stably adhere. After adhesion on collagen, a signaling cascade is initiated, mediated by Glycoprotein VI (GPVI), which results in platelet activation. A major signaling protein in GPVI signaling is Spleen tyrosine kinase (Syk). It undergoes phosphorylation and activation following GPVI stimulation. Syk's central role in this physiological process suggests regulation of its activity is required to maintain the platelets response to collagen within physiological limits. The regulation of Syk activation is the focus of this work.;Previously published reports implicate the phosphatases SHP-1, SHP-2 and TULA-2 in the negative regulation of Syk. Therefore, we tested these phosphatases possible role in platelets. We show that SHP-1 can dephosphorylate Syk in vitro, but is unable to bind Syk. Also, Syk is hypophosphorylated in GPVI-stimulated SHP-1 deficient platelets and platelet functional responses are minimally affected compared to wild-type platelets. SHP-2 is unable to bind Syk and Syk is not a good substrate for SHP-2 in vitro. TULA-2 dephosphorylated Syk in vitro and associated with Syk in platelets. In TULA-2 deficient platelets, Syk and PLCgamma2 were hyperphosphorylated compared to wild-type platelets. Deletion of TULA-2 resulted in enhanced GPVI-dependent platelet functional responses and a prothrombotic phenotype.;c-Cbl has been shown to be a negative regulator of GPVI signaling, possibly by regulating Syk phosphorylation. Thus, SHP-1, SHP-2 and TULA-2's role in c-Cbl regulation of GPVI was also investigated. We show that TULA-2 is able to bind c-Cbl in platelets. SHP-1 and SHP-2 do not. Furthermore, we show a striking similarity between the phenotype of TULA-2 and c-Cbl deficient platelets. However, in vitro binding studies show TULA-2 is able to bind Syk independently of c-Cbl. Thus, the exact role of c-Cbl in regulating Syk dephosphorylation is unclear.;In conclusion, we show SHP-1 and SHP-2 are probably not involved in the negative regulation of Syk. However, TULA-2 is the major phosphatase responsible for the negative regulation of Syk in GPVI signaling. This serves to negatively regulate GPVI-mediated platelet function and prevent uncontrolled platelet activation that could lead to thrombosis.
机译:血小板的活化对于止血至关重要。血管内皮损伤后,胶原蛋白被暴露出来,血小板稳定地附着在其上。在胶原上粘附后,由糖蛋白VI(GPVI)介导的信号级联反应开始,导致血小板活化。 GPVI信号传导中的主要信号传导蛋白是脾酪氨酸激酶(Syk)。 GPVI刺激后会发生磷酸化和激活。 Syk在此生理过程中的核心作用表明需要调节其活性,以将血小板对胶原的反应维持在生理范围内。 Syk激活的调控是这项工作的重点。先前发表的报告暗示磷酸酶SHP-1,SHP-2和TULA-2参与了Syk的负调控。因此,我们测试了这些磷酸酶在血小板中的可能作用。我们表明,SHP-1可以在体外使Syk磷酸化,但无法结合Syk。同样,Syk在GPVI刺激的SHP-1缺陷型血小板中被低磷酸化,与野生型血小板相比,血小板功能反应受到的影响最小。 SHP-2无法结合Syk,并且Syk在体外不是SHP-2的良好底物。 TULA-2在体外使Syk磷酸化,并与血小板中的Syk相关。与野生型血小板相比,在TULA-2缺陷型血小板中,Syk和PLCgamma2的磷酸化水平较高。 TULA-2的删除导致GPVI依赖性血小板功能反应增强和血栓形成前表型。c-Cbl已被证明是GPVI信号转导的负调节剂,可能是通过调节Syk磷酸化来实现的。因此,还研究了SHP-1,SHP-2和TULA-2在GPVI的c-Cbl调节中的作用。我们显示TULA-2能够结合血小板中的c-Cbl。 SHP-1和SHP-2没有。此外,我们在TULA-2和c-Cbl缺陷型血小板的表型之间显示出惊人的相似性。但是,体外结合研究显示TULA-2能够独立于c-Cbl结合Syk。因此,尚不清楚c-Cbl在调节Syk去磷酸化中的确切作用。总之,我们表明SHP-1和SHP-2可能不参与Syk的负调节。但是,TULA-2是负责GPVI信号传导中Syk负调控的主要磷酸酶。这可负调节GPVI介导的血小板功能,并防止可能导致血栓形成的不受控制的血小板活化。

著录项

  • 作者

    Thomas, Dafydd.;

  • 作者单位

    Temple University.;

  • 授予单位 Temple University.;
  • 学科 Health Sciences Pharmacology.;Biology Physiology.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 153 p.
  • 总页数 153
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号